Table 3

Microsatellite alteration of serum and tumor DNA and clinical data concerning breast cancer patients

Patient no.Age (yr)TypeaGradeNodepTNMD8S321D11S488D17S579D17S1325ACTBP2DM1UT5320
TSTSTSTSTSTSTS
3957IDC21/19pT2N1biMoLNINILL
4074DCISNILL
4157IDC20/10pT2NoMoNILL
4254IDC311/13pT3N1bivM1LNININILLLL
4357IDC+LCIS10/11pT1cNoMoNINI
4438IDC25/17pT2N1biiiMoLNINIL
4552IDC229/29pT2N1bivM1LNINININILL
4663DCISNINI
4768IDC20/10pT1cNoMoLNILLL
4844IDC22/11pT2N1bivMoL
4950IDC21/15pT2N1biiiMoNILLLNI
5060ILC20/15pT1cNoMoLNILNI
5170IDC2pT1cNxMoLLLL
5272IDC10/26pT1cNoMo
5350ILC20/13pT1cNoMoNILL
5483IDC30/13pT2NoMoLNILLNINIL
5557IDC20/19pT2NoMoNI
5671IDC30/8pT2NoMoLLLLLNIL
5782IDC3pT2NxMoNILLNI
5849IDC27/14pT2N1biiMoLNINILLNINIL
5964IDC21/17pT1cN1aMoLLL
6028BDNINI
6143BDLL
  • a IDC, invasive ductal carcinoma; DCIS, ductal carcinoma in situ; ILC, invasive lobular carcinoma; LCIS, lobular carcinoma in situ; BD, benign disease; T, tumor DNA; S, serum DNA; L, LOH; S, shift (appearance of new bands); −, absence of these findings; NI, not informative.